.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Farmers Insurance
Daiichi Sankyo
McKesson
Mallinckrodt
Healthtrust
Citi
Fuji
Harvard Business School
Federal Trade Commission

Generated: September 22, 2017

DrugPatentWatch Database Preview

Venlafaxine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for venlafaxine hydrochloride and what is the scope of venlafaxine hydrochloride freedom to operate?

Venlafaxine hydrochloride
is the generic ingredient in three branded drugs marketed by Dr Reddys Labs Ltd, Osmotica Pharm, Sandoz, Pliva Hrvatska Doo, Orchid Hlthcare, Prinston Inc, Sun Pharm Inds Inc, Alembic Pharms Ltd, Aurobindo Pharma Ltd, Yaopharma Co Ltd, Wyeth Pharms Inc, Zydus Pharms Usa, Heritage Pharms Inc, Aurobindo Pharma, Teva, Wockhardt, Mylan, Nostrum Labs Inc, Valeant Pharms North, Sun Pharma Global, Zydus Pharms Usa Inc, Anchen Pharms, Amneal Pharms, and Torrent Pharms Llc, and is included in twenty-eight NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Venlafaxine hydrochloride has eighty-seven patent family members in forty-four countries.

There are seventy drug master file entries for venlafaxine hydrochloride. Seventy-three suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: venlafaxine hydrochloride

Tradenames:3
Patents:5
Applicants:24
NDAs:28
Drug Master File Entries: see list70
Suppliers / Packagers: see list73
Bulk Api Vendors: see list61
Clinical Trials: see list2,415
Patent Applications: see list2,464
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:venlafaxine hydrochloride at DailyMed

Pharmacology for Ingredient: venlafaxine hydrochloride

Tentative approvals for VENLAFAXINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe37.5MGCAPSULE, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe150MGCAPSULE, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe75MGCAPSULE, EXTENDED RELEASE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL078932-003Dec 14, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL077515-005Jun 13, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Osmotica Pharm
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022104-001May 20, 2008ABRXYesNo► Subscribe► Subscribe ► Subscribe
Sun Pharma Global
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL091272-002Aug 18, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078421-001May 6, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-003Oct 20, 1997DISCNNoNo► Subscribe► SubscribeY► Subscribe
Amneal Pharms
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL079098-001May 11, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL078627-005Jun 13, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET;ORAL076690-005Aug 3, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-002Oct 20, 1997ABRXYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: venlafaxine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-001Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-004Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-001Oct 20, 1997► Subscribe► Subscribe
Osmotica Pharm
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022104-003May 20, 2008► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-003Dec 28, 1993► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-002Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-001Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR
venlafaxine hydrochloride
TABLET;ORAL020151-002Dec 28, 1993► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-002Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms Inc
EFFEXOR XR
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020699-001Oct 20, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: venlafaxine hydrochloride

Country Document Number Estimated Expiration
Germany69727000► Subscribe
Australia1640097► Subscribe
Taiwan555568► Subscribe
Estonia04577► Subscribe
CroatiaP20000213► Subscribe
South Korea101096512► Subscribe
Uruguay25692► Subscribe
Egypt24198► Subscribe
Czech Republic20001659► Subscribe
China1403077► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Queensland Health
Cipla
Chubb
McKesson
Citi
Harvard Business School
Farmers Insurance
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot